Effetti del NADH

 

NADH-supplementation decreased pinacidil-primed I K(ATP) in ventricular cardiomyocytes by increasing intracellular ATP

Pelzmann B, Hallström S, Schaffer P, Lang P, Nadlinger K, Birkmayer GD, Vrecko C, Reibnegger G and Koidl B.

Brit. J. Pharm. 2003 139, 749-754.

 


 

The Reduced Coenzyme Nicotinamide Adenine Dinucleotide (NADH) repairs DNA damage of PC12 cells induced by doxorubicin

Zhang JR, Vrecko K, Nadlinger K, Storga D, Birkmayer GD, Reibnegger G

J. Tumor Marker Oncol. 1998; 13, 5-17.

 


 

X-ray induced LO2 cells damage rescued by new antioxidant NADH

Fa-Quan L, Zhang JR.

World J. Gastorenterol. 2003, 9(8): 1781-1785.

 


 

The Cytoprotection of Nicotinamide Adenine Dinucleotide (NADH) by the Mitochondrial Regulation Mechanism

Meng Xu, Hang JR, Hui SSC

J. Tumor Marker Oncol. 1998; 17: 167 – 174.

 


 

The antioxidative capacity of ENADA®-NADH in humans

Reibnegger G, Greilberger J, Juergens G. and Oettl K.

J. Tumor Marker Oncol. 2003; 18, 37-41.

 


 

Oral NADH effects blood pressure, lipid peroxidation and lipid profile in spontaneously hypertensive rats

Busheri N, Taylor J, Lieberman S, Mirdamadi-Zonosi N, Birkmayer G, Preuss HG

Geriat. Nephrol. Urol. 1998; 18(2) 95-100.

 


 

Influence of reduced Nicotinamide Adenine Dinucleotide (NADH) on the production of Interleukin-6 by peripheral human blood leucocytes

Nadlinger K, Birkmayer J, Gebauer F, Kunze R

Neuroimmunomodulation, 2002; 9: 203-208.

 


 

NADH stimulates endogenous dopamine biosynthesis by enhancing the recycling of tetrahydrobiopterin in rat phaechromocytoma cells

Vrecko K, Storga D, Birkmayer GD, Möller R, Tarfeit E, Horejsi R, Reibnegger G

Biochimica et Biophysica Acta 1997; 1361: 59-65.

 


 

NADH: Sensor of blood flow in brain, muscle and other tissues

Ido Y., Chang K., Woosley TA, Willimanson JR

FASEB, 2001; 15: 1419- 1421.

 


 

 

 

Stabilità, biodisponibilità e sicurezza del NADH

 


 

On the Safety of Reduced Nicotinamide Adenine Nucleotide (NADH)

Birkmayer JGD, Nadlinger K, Hallström S.

Journal Environmental Pathology, Toxicology and Oncology 2004; 23: 179-194.

 


 

Safety of stabilized, orally absorbable, reduced nicotinamide adenine dinucleotide (NADH): A 26-week oral tablet administration of ENADA®/NADH for chronic toxicity study in rats

Birkmayer JGD, Nadlinger K.

Drugs experimental clinical Research 2002; 28: 185-182.

 

 

 

Applicazioni e benefici del NADH

 

Morbo di Parkinson

 

Nicotinamide adenine dinucleotide (NADH) – a new therapeutic approach to Parkinson’s disease: Comparison of oral and parenteral application

Birkmayer JGD, Vrecko C, Volc D, Birkmayer W

Acta Neurol Scand. 1993; 87: 32-35.

 


 

Stimulation of dopamine biosynthesis in culture PC12 pheochromocytoma cells by the coenzyme nicotinamide adenine dinucleotide (NADH)

Vrecko K, Birkmayer JGD, Krainz J.

J.Neural.Transm. 1993; 5: 147-156.

 

 

 

Depressione

 

The reduced nicotinamide adenine dinucleotide (NADH) as biological antidepressive agent. Experience with 205 patients

Birkmayer JGD, Birkmayer W

New trends in Clinical Neuropharmacology 1991; 5: 75-86.

 

 

 

Sindrome da fatica cronica

 

The therapeutic effect of NADH in patients with Chronic Fatigue Syndrome

Forsyth L, Preuss. H, Carneiro ML, Chiazze R, Birkmayer GD, Bellanti J

Ann. Allergy Asthma and Immunol., 199.9; 82: 185-191.

 

 

 

 

Morbo di Alzheimer

 

Treatment of Alzheimer’s Disease with stabilized oral Nicotinamide Adenine Dinucleotide: A randomized, double-blind study

Demarin V, Podobnik-Sarkanji S, Storga-Tomic D, Kay G

Drugs exptl. Clin.Res. 2004; 30: 327-337.

 


 

ENADA/NADH improves cognitive impairment of Alzheimer patients

Demarin V, Podobnik-Sarkanji S, Storga-Tomic D, Kay G, Martinic-Popovic,M. Puretic B., Birkmayer JGD

J. Tumor Marker Oncology 2003; 18:43-49.

 

 

 

Cancro

 

NADH in Cancer Prevention and Therapy

Birkmayer JGD, Zhang JR, ed. Bagchi D, Preuss H

CRC Press 2005; chapter 33, 541- 554.

 

 

 

Prestazione fisica e mentale

 

Einfluss einer NADH Supplementation auf die muskuläre Energiebereitstellung beim Menschen (Influence of NADH supplementation for the muscular energy supply in humans)

Grathwohl D, Klann M, Müller HM, Schlachter H, Berg A.

Deutsche Zeitschrift für Sportmedizin, 11/2000.

 


 

ENADAlert® improves physical and mental performance in highly conditioned athletes

Birkmayer GD, Nadlinger K.

J. Tum. Marker Oncol. 2003; 18: 51-55.

 

 

 

Jet lag e privazione del sonno

 

Effectiveness of NADH in Alleviating Effects of Sleep Deprivation in Healthy Middle-Aged Adults

Moline ML.

Study Abstract Cornell University, Sleep Wake Disorder Center December 2001.

 


 

Stabilisiertes NADH (ENADA) verbessert die durch Jet Lag reduzierte Hirnleistung (Stabilized NADH as Counter Measure for Jet Lag)

Birkmayer JGD, Kay GG, Virre ES

Wiener Med. Wochenschr. 2002; 17/18: 450-454.

 


 

Jet Lag und Schlafentzug – Verminderung der Hirnleistung Das Coenzym NADH bessert die Symptome

Birkmayer Joerg

Flugmedizin 2002; 9: 41-44.

 

 

 

Menopausa

 

NADH – neue Wege in der Behandlung des klimakterischen Syndroms

Friedrich F, Nadlinger K, Birkmayer JGD, Friedrich F

J. Menopause 2006, 10:10-12.

 

 

 

Applicazioni cosmetiche e dermatologiche

 

Computergestützte Kapillaroskopie der Haut – ein neues diagnostisches Verfahren in der ästhetischen Medizin

Mustafina F.K., Mustafin T.K., Lasuk A.V.

Kosmetik und ästhetische Medizin, 02/2018.

 


 

Ointment Preparation containing NADH in Teleangiectasis

Augustin M, Zschocke I

Final Biometric Report, Universitäts Hautklinik, Freiburg, Germany Okt. 2000.

 

 

 

Monografie sul NADH

 

NADH – Biologische Funktionen und ernährungsphysiologische Anwendungen

Joerg Birkmayer

ERNO 2000; 1: 71 – 76